TABLE 1 Global Biologics Market By Product, 2022-2032, USD (Million)
TABLE 2 Global Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 3 Global Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 4 Global Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 5 Global Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 6 North America Biologics Market By Product, 2022-2032, USD (Million)
TABLE 7 North America Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 8 North America Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 9 North America Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 10 North America Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 11 U.S. Biologics Market By Product, 2022-2032, USD (Million)
TABLE 12 U.S. Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 13 U.S. Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 14 U.S. Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 15 U.S. Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 16 Canada Biologics Market By Product, 2022-2032, USD (Million)
TABLE 17 Canada Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 18 Canada Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 19 Canada Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 20 Canada Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 21 Rest of North America Biologics Market By Product, 2022-2032, USD (Million)
TABLE 22 Rest of North America Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 23 Rest of North America Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 24 Rest of North America Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 25 Rest of North America Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 26 UK and European Union Biologics Market By Product, 2022-2032, USD (Million)
TABLE 27 UK and European Union Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 28 UK and European Union Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 29 UK and European Union Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 30 UK and European Union Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 31 UK Biologics Market By Product, 2022-2032, USD (Million)
TABLE 32 UK Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 33 UK Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 34 UK Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 35 UK Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 36 Germany Biologics Market By Product, 2022-2032, USD (Million)
TABLE 37 Germany Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 38 Germany Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 39 Germany Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 40 Germany Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 41 Spain Biologics Market By Product, 2022-2032, USD (Million)
TABLE 42 Spain Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 43 Spain Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 44 Spain Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 45 Spain Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 46 Italy Biologics Market By Product, 2022-2032, USD (Million)
TABLE 47 Italy Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 48 Italy Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 49 Italy Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 50 Italy Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 51 France Biologics Market By Product, 2022-2032, USD (Million)
TABLE 52 France Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 53 France Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 54 France Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 55 France Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 56 Rest of Europe Biologics Market By Product, 2022-2032, USD (Million)
TABLE 57 Rest of Europe Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 58 Rest of Europe Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 59 Rest of Europe Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 60 Rest of Europe Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 61 Asia Biologics Market By Product, 2022-2032, USD (Million)
TABLE 62 Asia Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 63 Asia Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 64 Asia Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 65 Asia Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 66 China Biologics Market By Product, 2022-2032, USD (Million)
TABLE 67 China Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 68 China Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 69 China Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 70 China Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 71 Japan Biologics Market By Product, 2022-2032, USD (Million)
TABLE 72 Japan Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 73 Japan Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 74 Japan Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 75 Japan Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 76 India Biologics Market By Product, 2022-2032, USD (Million)
TABLE 77 India Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 78 India Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 79 India Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 80 India Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 81 Australia Biologics Market By Product, 2022-2032, USD (Million)
TABLE 82 Australia Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 83 Australia Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 84 Australia Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 85 Australia Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 86 South Korea Biologics Market By Product, 2022-2032, USD (Million)
TABLE 87 South Korea Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 88 South Korea Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 89 South Korea Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 90 South Korea Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 91 Latin America Biologics Market By Product, 2022-2032, USD (Million)
TABLE 92 Latin America Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 93 Latin America Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 94 Latin America Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 95 Latin America Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 96 Brazil Biologics Market By Product, 2022-2032, USD (Million)
TABLE 97 Brazil Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 98 Brazil Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 99 Brazil Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 100 Brazil Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 101 Mexico Biologics Market By Product, 2022-2032, USD (Million)
TABLE 102 Mexico Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 103 Mexico Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 104 Mexico Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 105 Mexico Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 106 Rest of Latin America Biologics Market By Product, 2022-2032, USD (Million)
TABLE 107 Rest of Latin America Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 108 Rest of Latin America Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 109 Rest of Latin America Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 110 Rest of Latin America Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 111 Middle East and Africa Biologics Market By Product, 2022-2032, USD (Million)
TABLE 112 Middle East and Africa Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 113 Middle East and Africa Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 114 Middle East and Africa Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 115 Middle East and Africa Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 116 GCC Biologics Market By Product, 2022-2032, USD (Million)
TABLE 117 GCC Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 118 GCC Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 119 GCC Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 120 GCC Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 121 Africa Biologics Market By Product, 2022-2032, USD (Million)
TABLE 122 Africa Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 123 Africa Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 124 Africa Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 125 Africa Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)
TABLE 126 Rest of Middle East and Africa Biologics Market By Product, 2022-2032, USD (Million)
TABLE 127 Rest of Middle East and Africa Biologics Market By Recombinant Therapeutic Proteins, 2022-2032, USD (Million)
TABLE 128 Rest of Middle East and Africa Biologics Market By Disease, 2022-2032, USD (Million)
TABLE 129 Rest of Middle East and Africa Biologics Market By Oncology, 2022-2032, USD (Million)
TABLE 130 Rest of Middle East and Africa Biologics Market By Autoimmune diseases, 2022-2032, USD (Million)